Core Insights - Enzo Biochem, Inc. has qualified to trade on the OTCQX Best Market, transitioning from the New York Stock Exchange [1][2] - The OTCQX Market provides companies with efficient and cost-effective access to U.S. capital markets, with streamlined requirements aimed at reducing costs and complexity for public trading [3] Company Overview - Enzo Biochem, Inc. has been a life sciences company for over 45 years, focusing on labeling and detection technologies, with a comprehensive portfolio of thousands of high-quality products [5] - The company's primary business is conducted through its Life Sciences division, which plays a central role in translational research and drug development [5] Market Context - OTC Markets Group Inc. operates regulated markets for trading 12,000 U.S. and international securities, with data-driven disclosure standards forming the foundation of its public markets [6] - The OTC Link Alternative Trading Systems provide critical market infrastructure for broker-dealers, facilitating trading and offering companies more efficient access to U.S. financial markets [7]